It was found that most amount of objections were filed for examination fees and outpatient prescription drugs after the Health and Insurance Review Service's adjustments such as cutbacks on items that do not meet the review criteria for insurance benefits.

HIRA had recently held a ‘2021 Briefing session on filing objections’ for medical care institutions.

In the session, HIRA introduced cases of 1st adjustments after review that received the most amount of objections. By each treatment category, objections filed for examination fees accounted for 23%, followed by outpatient prescription drugs 20%, emergency aid and operation fees 17%, and injection fees 12%.